DECALIA Capital and founding shareholders have sold MediGroup to ImaOne, a portfolio company of Bpifrance and Eurazeo

MediGroup Holding

MediGroup is a leading outpatient radiology platform in Swiss Romandie, operating a network of five high-quality medical imaging centers. Founded in 2015, the company has developed from a single-center provider into one of the leading pure-play radiology platforms in the region, offering diagnostic imaging and image-guided intervention services across MRI, CT-scan, X-Ray, ultrasound and mammography. The company is recognized for its high-quality care, highly regarded radiologists and modern, well-invested medical imaging equipment. Through continued modernization of its machine park, early adoption of teleradiology and a broad network of referring physicians, MediGroup has established itself as a trusted radiology partner for patients, hospitals, general practitioners and specialists across Western Switzerland.

The Deal

Lincoln International ran a broad and competitive process with strong engagement from strategic and financial investors. The transaction was completed amid the regulatory transition from TARMED to TARDOC, a major reform of the Swiss outpatient tariff system, and marks one of the first Swiss outpatient transactions agreed in this new reimbursement environment. The successful outcome highlights the attractiveness of scalable radiology platforms with strong fundamentals, efficient operations and the ability to adapt to evolving market conditions. The acquisition represents a highly strategic step for ImaOne by expanding its Swiss presence beyond its existing Geneva footprint.

Our Perspective

Dirk-Oliver Löffler, Lincoln International Managing Director and Co-Head of Healthcare, Europe, commented, “We are pleased to have advised DECALIA Capital and the minority shareholders on this landmark transaction in Swiss outpatient radiology. MediGroup is a high-quality platform, built around leading radiologists, a strong medical reputation and a modern, well-invested imaging infrastructure. The transaction demonstrates the continued strategic relevance of well-run diagnostic imaging platforms where trusted doctors, operational excellence and consistent service quality are key differentiators.”

Andy Roth, Director in Lincoln’s European Healthcare Group, added, “MediGroup’s strong position in Swiss Romandie created a compelling strategic fit with ImaOne. Against the backdrop of the TARMED / TARDOC transition, the outcome highlights the quality of MediGroup’s outpatient radiology model. It also adds to Lincoln Switzerland’s successful track record in Swiss Romandie.”

DECALIA Capital

DECALIA Capital is a Swiss investment management company based in Geneva, Zurich and Milan. Under DECALIA Capital’s ownership, MediGroup developed into one of the leading radiology platforms in Swiss Romandie, backing the company’s growth, modernization and continued professionalization.

ImaOne

ImaOne is a leading doctor-led medical imaging platform active across France and Switzerland, combining radiology and nuclear medicine. The group operates a network of more than 25 high-quality centers, supported by specialized doctors, modern equipment and a strong focus on clinical excellence. Backed by Bpifrance and Eurazeo, ImaOne is pursuing a targeted growth strategy to build a leading European diagnostic imaging platform. Through the acquisition of MediGroup, ImaOne further strengthens its Swiss presence and expands its position in French-speaking Switzerland.

Share: